List view / Grid view
Drug Target Review explores the findings of a recent review of molecular, cellular, multi-cellular and tissue engineering and modelling technologies for drug design.
Scientists have demonstrated an innovative technique for creating microparticles for tissue engineering out of a combination of disordered and partially ordered proteins.
A study has shown that using a particular three-stranded structure can extend the catalytic performance of artificial metalloenzymes.
Scientists have showed that a three inhibitors (3i) cocktail could reprogramme fibroblasts to a naïve embryonic stem cell-like state and remove disease-associated epigenetic changes.
Scientists have shown an innovative new biomaterial made of graphene oxide and proteins could be used to 3D print model vascular structures.
Drug Target Review spoke with CUE Biopharma’s President and CSO to find out how and why they created the ImmunoSTAT platform and the ways it may benefit drug design in the future.
Drug Target Review explores the latest applications of stem cells in modelling disease, drug production and the most recent steps in regenerative medicine provided by research.
Endogenous human antibodies can be used to build and dismantle 2D and 3D DNA nanostructures, finds new research.
Immunogens can be used to coax the immune system into producing broadly neutralising antibodies to fight a HIV infection, making a vaccine against the condition more likely, say researchers.
Researchers have reprogrammed CAR T cells to prevent them becoming exhausted after prolonged activity, presenting a possible new therapy for solid tumours.
Scientists have developed a new method that accelerates the design and engineering of potential medicines and vaccines using glycosylation.
Researchers in Spain have achieved functional recovery from a stroke after implanting silk fibroin hydrogels-encapsulated stem cells in stroke mice.
Human eggs have been fully grown in a laboratory, in a move that could lead to improved fertility treatments...
Scientists in Denmark have made it possible to rank the risk of resistance genes and predict the evolution of existing and future drugs.
Researchers in Spain have developed a method of gene therapy that cures pulmonary fibrosis in mice by lengthening telomeres – the protective protein sections at the end of chromosomes.
